Free Trial
CVE:VIV

Avivagen (VIV) Stock Price, News & Analysis

Avivagen logo
C$0.0050 0.00 (0.00%)
As of 03/5/2024

About Avivagen Stock (CVE:VIV)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.08
Volume
2,820 shs
Average Volume
49,827 shs
Market Capitalization
C$388.45 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VIV Stock News Headlines

Avivagen Inc (VIV)
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Pure Harvest Corporate Group, Inc. (PHCG)
Closing Bell: Avivagen Inc flat on Monday (VIV)
Avivagen Announces New 500Kg Order for OxC-beta™
See More Headlines

VIV Stock Analysis - Frequently Asked Questions

Avivagen's stock was trading at C$0.01 at the beginning of 2025. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01.

Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avivagen investors own include AtkinsRéalis (SNCAF) and ProMetic Life Sciences (PLI).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
Current Symbol
CVE:VIV
CIK
N/A
Fax
N/A
Employees
34,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.64 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-193.44%

Debt

Debt-to-Equity Ratio
2,402.32
Current Ratio
0.03
Quick Ratio
0.30

Sales & Book Value

Annual Sales
C$403.78 thousand
Price / Sales
0.96
Cash Flow
C$0.00 per share
Price / Cash Flow
12.14
Book Value
C($0.12) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
77,690,000
Free Float
N/A
Market Cap
C$388.45 thousand
Optionable
Not Optionable
Beta
1.06
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:VIV) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners